Amicus Therapeutics (FOLD) Announces Positive Migalastat Phase 3 Data in Fabry Disease
Tweet Send to a Friend
Amicus Therapeutics (NASDAQ: FOLD) announced positive data on pre-specified patient reported outcomes from both of its Phase 3 studies of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE